价格

I-1

未知生产厂商

生成 AI 研报

专利

每项发明一条，涵盖美国、欧洲、PCT 与中国的同族专利。

Methods for purification of alpha-1-antitrypsin and apolipoprotein a-i
EP 2520583 A1申请人: CSL BEHRING GMBH优先权: 2007
CN
EP
US
10 件公开
2-(3-PYRIDIN-2-YL-4-QUINOLIN-4-YL-PYRAZOL-1-YL)-ACETAMIDE DERIVATIVES AS INHIBITORS OF TRANSFORMING GROWTH FACTOR-BETA RECEPTOR I/ALK5
EP 4781988 A2申请人: AGOMAB SPAIN S L U优先权: 2020
CN
EP
US
WO
8 件公开
RECEPTOR BINDING AGENTS
EP 4219538 A3申请人: BUZZARD PHARMACEUTICALS AB优先权: 2010
CN
EP
US
7 件公开
(2S)-N-[(1S)-1-CYANO-2-PHENYLETHYL]-1,4-OXAZEPANE-2-CARBOXAMIDES AS DIPEPTIDYL PEPTIDASE I INHIBITORS
EP 3744714 B1申请人: ASTRAZENECA AB优先权: 2014
CN
EP
WO
7 件公开
I domain chimeric antigen receptor specific to ICAM-1
US 10428136 B2申请人: UNIV CORNELL优先权: 2016
CN
US
7 件公开
TRICYCLIC QUINOLONE BCL6 BIFUNCTIONAL DEGRADERS
- EP 4536650 A1
  申请人: TREELINE BIOSCIENCES INC优先权: 2022
  CN
  EP
  US
  WO
  6 件公开
- EP 4771013 A1
  申请人: TREELINE BIOSCIENCES INC优先权: 2023
  CN
  EP
  WO
  3 件公开
Combination therapy comprising compounds of formula (I) and GLP-1 receptor agonists
US 12458612 B2申请人: GENFIT优先权: 2019
CN
EP
US
WO
5 件公开
Recombinant humanized collagen type I alpha-1 (rhCol1A1), and expression vector and use thereof
US 12319926 B2申请人: SHANDONG D NUTRIMEC BIOMEDICAL CO LTD优先权: 2023
CN
EP
US
WO
5 件公开
Combined T cell receptor gene therapy of cancer against MHC I and MHC II-restricted epitopes of the tumor antigen NY-ESO-1
EP 3067366 A1申请人: MAX DELBRÜCK CT FÜR MOLEKULARE MEDIZIN优先权: 2015
CN
EP
US
5 件公开
1,8-NAPHTHYRIDIN-2-ONE HETEROBIFUNCTIONAL BCL6 DEGRADERS
EP 4536658 A1申请人: TREELINE BIOSCIENCES INC优先权: 2022
CN
EP
US
WO
4 件公开

药物

I-1

专利

TRICYCLIC QUINOLONE BCL6 BIFUNCTIONAL DEGRADERS